Edmond M Kwan

17PUBLICATIONS
84CO-AUTHORS
Molecular targetsRadiation therapyPredictive and prognostic markersCancer geneticsInstrumental methods (excl. immunological and bioassay methods)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 28, 2026
NanoString profiling of DNA repair and apoptosis genes in testicular germ cell tumours with divergent chemotherapy outcomes.

|Aug 27, 2026
Advancing Homologous Recombination Repair Mutation Testing in Prostate Cancer in Australia: Shifting the Focus to Hormone Sensitive Prostate Cancer.

|Feb 06, 2026
Clonal Hematopoiesis after 177Lu-PSMA-617 Radioligand Therapy in Prostate Cancer.

Aslı D Munzur, Cameron Herberts, Edmond M Kwan

|May 27, 2025
Lutetium-177-PSMA-617 or cabazitaxel in metastatic prostate cancer: circulating tumor DNA analysis of the randomized phase 2 TheraP trial.

Edmond M Kwan, Sarah W S Ng, Sofie H Tolmeijer

|Apr 25, 2025
p-AKT Protein Expression Predicts Response to AKT Inhibitor Combined with Docetaxel Therapy in Adenocarcinoma and Neuroendocrine Prostate Cancer.

Hipacia Werneck Gomes, Natalie L Lister, Shivakumar Keerthikumar

|Dec 09, 2024
Plasma Cell-Free DNA Chromatin Immunoprecipitation Profiling Depicts Phenotypic and Clinical Heterogeneity in Advanced Prostate Cancer.

Joonatan Sipola, Aslı D Munzur, Edmond M Kwan

Pageof 3

Frequent Collaborators

7 joint publications

Arun A Azad

6 joint publications

Alexander W Wyatt

5 joint publications

Cameron Herberts

4 joint publications

Anthony M Joshua